Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoya Uchida

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Molecular Therapy. Nucleic Acids|September 19, 2013
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy NumberNaoya Uchida, Molly E Evans, Matthew M Hsieh, et al.
Stem Cell Research|November 12, 2019
Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture systemJuan Pablo Ruiz, Guibin Chen, Juan Jesus Haro Mora, et al.
Experimental Hematology|June 8, 2019
Fetal hemoglobin and F-cell variance in mobilized CD34<sup>+</sup> cell-transplanted rhesus monkeysSelami Demirci, Juan J Haro Mora, Morgan Yapundich, et al.
Experimental Hematology|May 10, 2011
Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixaforNaoya Uchida, Aylin Bonifacino, Allen E Krouse, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2019
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque ModelNaoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
American Journal of Hematology|September 26, 2022
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 studyJulie Kanter, Alexis A Thompson, Francis J Pierciey, et al.
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Cell Reports|May 20, 2014
Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate modelSo Gun Hong, Thomas Winkler, Chuanfeng Wu, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Haematologica|October 15, 2020
Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixaforNaoya Uchida, Alexis Leonard, David Stroncek, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Molecular Therapy. Nucleic Acids|September 19, 2013
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy NumberNaoya Uchida, Molly E Evans, Matthew M Hsieh, et al.
Stem Cell Research|November 12, 2019
Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture systemJuan Pablo Ruiz, Guibin Chen, Juan Jesus Haro Mora, et al.
Experimental Hematology|June 8, 2019
Fetal hemoglobin and F-cell variance in mobilized CD34<sup>+</sup> cell-transplanted rhesus monkeysSelami Demirci, Juan J Haro Mora, Morgan Yapundich, et al.
Experimental Hematology|May 10, 2011
Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixaforNaoya Uchida, Aylin Bonifacino, Allen E Krouse, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2019
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque ModelNaoya Uchida, Tina Nassehi, Claire M Drysdale, et al.
American Journal of Hematology|September 26, 2022
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 studyJulie Kanter, Alexis A Thompson, Francis J Pierciey, et al.
British Journal of Haematology|June 23, 2022
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell diseaseAkshay Sharma, Alexis Leonard, Kamille West, et al.
Cell Reports|May 20, 2014
Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate modelSo Gun Hong, Thomas Winkler, Chuanfeng Wu, et al.
Blood Advances|May 6, 2021
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell diseaseAlexis Leonard, Akshay Sharma, Naoya Uchida, et al.
Haematologica|October 15, 2020
Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixaforNaoya Uchida, Alexis Leonard, David Stroncek, et al.
Pageof 9